Authors
Latest:
Measuring Pharma’s Wider MandateEspecially critical amid the continuing global pandemic, key metrics are laid out to help life sciences companies define, measure, and effectively communicate sustainability practices and progress—and build foundations for long-term business value.
Latest:
Strategies for Success in an Evolving Commercialization LandscapeA phased launch approach may ultimately be more sustainable and enable maximum market penetration and commercial success with less upfront investment than traditional “go-for-broke” strategies.
Latest:
Embracing Digital Education During COVID-19 CrisisAs the world of medicine continues to face the impact of the COVID-19 pandemic, clinicians are increasingly looking to digital solutions, including continuing medical education (CME), to stay current on the latest developments in their field.
Latest:
Advancing Health Innovation in 2022: Where Should We Focus?What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?
Latest:
How Digital Twins Drive Sustainability in Clinical Supply PlanningEmerging technologies like digital twins offer supply chain efficiency solutions, allowing the industry to integrate sustainable practices while ensuring patient safety.
Latest:
NFTs: What This New Kid on the Blockchain Means for HealthcareThere has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.
Latest:
How GxP Leaders Can Assess and Approach a Company’s Quality CultureUsing the interview process to ensure high organizational standards.
Latest:
Securing the Safety Net in Drug Access and SupportA look at the intersection of rigorous compliance and ethical behavior: independent, charitable patient assistance foundations.
Latest:
Next-level Efficacy: MounjaroDual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.
Latest:
Top Five Trends in Life Sciences Compliance for 2022Patient protection and social influence among trends to look out for as calendar turns.
Latest:
The Influence of PD-1 Inhibitor Label Restrictions on Future StudiesRon Lanton, Partner, Lanton Law, ways that the recent FDA PD-1 inhibitor label restrictions could influence future drug development strategies.
Latest:
Virtual Medical Affairs Audits: A Viable AlternativeVirtual audits proving to be beneficial post-COVID despite continuing challenges.
Latest:
The Case for Market Access...Early and OftenIndustry veteran Ken Abreu makes the case for approaching market access very early in the process, and elucidates why it's so important.
Latest:
12 Healthcare Provider Pharma Social Media Predictions for 2022Social Media is omnipresent and harnessing its power should be high on lists of healthcare providers (HCPs). How do they get their message out to reach the right people at the right time and how do they distinguish themselves from their competitors? Here are 12 predictions and factors for 2022.
Latest:
Seven Lessons I Learned Working at a Biotech StartupHow early stage can help set you up for big stage.
Latest:
The Effects of Ransomware on Science & Its ResearchersLife sciences companies a likely targets of these kinds of attacks.
Latest:
Exploring the “Other” End-User – HCPs and the Challenges to Adoption of Machine Learning-based Digital SolutionsWebinar Date/Time: Mon, Dec 5, 2022 2:00 PM EST
Latest:
Using Real-World Data to Examine Long-Term Safety and Effectiveness in Extension StudiesLeveraging RWD can lessen the strain normally put on investigators and sites.
Latest:
Making Medication Assistance Program Solutions Work for YouHow technology can maximize use of manufacturer copay and patient assistance programs.
Latest:
Navigating the Future: Key Market Access Trends to Watch in ’24Five emerging themes likely to impact pharma in the new year.
Latest:
Capitalizing On Collaboration and Confidence: Survey Insights and Expectations For Biotech in 2024Dr. Chris Smyth, president of ICON Biotech, discusses emerging trends in the biotech space.
Latest:
New Horizons for Patient-Centric Drug DeliveryOral solid dose formulations (OSD) continue to lead the market as a preferred dosage form. To gain better insight into drug dose delivery technology trends, Laura Child spoke to leaders from five top contract development and manufacturing organizations to find out what is on the horizon for patient-centric drug delivery.
Latest:
Biopharma and ESG: Key Strategies for Companies, Meaningful Changes to CommunitiesNew regulations set stage for updated ESG considerations.
Latest:
Lessons Learned on the Art and Science of Product CommercializationInsight that can help smaller biotech companies prepare for commercialization in the world of big pharma.
Latest:
Investing for Success: Finding the Right Launch BalanceChallenge assumptions and reset expectations when it comes to pre-launch SG&A investment to increase the odds of commercial success.
Latest:
2021 Projections on the Future of Patient Engagement in PharmaOn the back of COVID-19, pharma has an opportunity to radically rethink a long-held reluctance to build end-customer relationships into their core business models, writes Simon Bates and Valerie Phillips.
Latest:
Commercial Sustainability of Pharmaceutical Innovations for PandemicsAssessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.
